MARKET

RXRX

RXRX

Recursion Pharmaceuticals, Inc.
NASDAQ
3.520
+0.180
+5.39%
After Hours: 3.520 0 0.00% 19:59 06/26 EDT
OPEN
3.290
PREV CLOSE
3.340
HIGH
3.620
LOW
3.282
VOLUME
42.59M
TURNOVER
--
52 WEEK HIGH
7.18
52 WEEK LOW
2.770
MARKET CAP
1.87B
P/E (TTM)
-2.9233
1D
5D
1M
3M
1Y
5Y
1D
BABA, COIN, PLTR, SPCX: Cathie Wood Dumps $54 Million of Alibaba Stock, Buys More Coinbase, Palantir and SpaceX
TipRanks · 13h ago
Nvidia Owns This Under-the-Radar $20 Stock Poised to Disrupt a $1.8 Trillion Market
The Motley Fool · 19h ago
PLTR, CBRS, HOOD – Cathie Wood Buys Beaten-Down Tech Stocks, Sells Alibaba and ROKU
TipRanks · 1d ago
2 Beaten-Down Artificial Intelligence (AI) Stocks for Contrarian Investors to Consider Buying
The Motley Fool · 2d ago
Cathie Wood’s ARK Investment buys 260K shares of Recursion Pharmaceuticals today
TipRanks · 3d ago
Recursion Pharmaceuticals (RXRX) Ascends While Market Falls: Some Facts to Note
NASDAQ · 3d ago
1 of the Most Interesting AI Stocks in the Market Isn’t a Tech Company
Barchart · 4d ago
Recursion Pharmaceuticals director Bumpus Namandje disposes of 3,963 common shares worth $12,599.34
PUBT · 5d ago
More
About RXRX
Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio company decoding biology and chemistry to industrialize drug discovery. Its Recursion Operating System (OS), a platform built across diverse technologies, enables the Company to map and navigate trillions of biological and chemical relationships within the Recursion Data Universe. The Company integrates physical and digital components as iterative loops of atoms and bits, scaling wet lab biology and chemistry data organized into virtuous cycles with computational tools to rapidly translate silico hypotheses into validated insights and novel chemistry. Its clinical programs in oncology and rare diseases include REC-617, REC-1245, REC-3565 and REC-4539. Its REC-617 is an orally bioavailable, cyclin-dependent kinase 7 (CDK7) inhibitor for the treatment of advanced solid tumors. Its REV102 program targets ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1), an enzyme implicated in the pathogenesis of HPP.

Webull offers Recursion Pharmaceuticals Inc stock information, including NASDAQ: RXRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RXRX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RXRX stock methods without spending real money on the virtual paper trading platform.